Cargando…
Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations
BACKGROUND: Infantile hypercalcaemia (IH) is a vitamin D(3) metabolism disorder. The molecular basis for IH is biallelic mutations in the CYP24A1 or SLC34A1 gene. These changes lead to catabolism disorders (CYP24A1 mutations) or excessive generation of 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] (S...
Autores principales: | Janiec, Agnieszka, Halat-Wolska, Paulina, Obrycki, Łukasz, Ciara, Elżbieta, Wójcik, Marek, Płudowski, Paweł, Wierzbicka, Aldona, Kowalska, Ewa, Książyk, Janusz B, Kułaga, Zbigniew, Pronicka, Ewa, Litwin, Mieczysław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311581/ https://www.ncbi.nlm.nih.gov/pubmed/33099630 http://dx.doi.org/10.1093/ndt/gfaa178 |
Ejemplares similares
-
Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases
por: Pronicka, Ewa, et al.
Publicado: (2017) -
Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy
por: Śladowska-Kozłowska, Joanna, et al.
Publicado: (2012) -
Central systolic blood pressure and central pulse pressure predict left ventricular hypertrophy in hypertensive children
por: Litwin, Mieczysław, et al.
Publicado: (2018) -
Genetic causes of neonatal and infantile hypercalcaemia
por: Gorvin, Caroline M.
Publicado: (2021) -
Obesity, metabolic syndrome, and primary hypertension
por: Litwin, Mieczysław, et al.
Publicado: (2020)